SpotSee acquired Telatemp, expanding SpotSee’s product portfolio and strengthening its presence in critical life science applications.
“ColdSnap has earned the confidence of industries that demand precision and reliability, especially in the life sciences space,” says Tony Fonk, CEO of SpotSee. “By bringing Telatemp into the SpotSee portfolio, we’re reinforcing our commitment to delivering best-in-class monitoring solutions for the safe transportation of vital products like heart valves and biologics.”
Key takeaways:
· A key addition from the acquisition is ColdSnap, Telatemp’s field-armable descending time-over-temperature indicator, widely used in pharmaceutical and laboratory applications where freezing can be detrimental to injectable medicines or tissues such as heart valves. The ColdSnap family of products enhances SpotSee’s suite of solutions and deepens its capabilities in regulated cold chain environments.
· As part of the integration, the Telatemp brand will be retired and all products will be consolidated under the SpotSee brand.
